Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > EV / Sales (ntm)

Acadia Pharmaceutica EV / Sales (ntm) Chart (ACAD)

Acadia Pharmaceutica annual/quarterly EV / Sales (ntm) from 2010 to 2020.
  • Acadia Pharmaceutica EV / Sales (ntm) for the quarter ending October 10, 2020 was 13.06 a 9.77% increase of 1.28 year over year
  • Acadia Pharmaceutica EV / Sales (ntm) for the last 12 months ending October 10, 2020 was 13.06 a 9.77% increase of 1.28 year over year
  • Acadia Pharmaceutica Annual EV / Sales (ntm) for 2020 was 13.06 a 3.53% increase of 0.46 from 2019
  • Acadia Pharmaceutica Annual EV / Sales (ntm) for 2020 was 12.60 a 4.16% increase of 0.52 from 2019
  • Acadia Pharmaceutica Annual EV / Sales (ntm) for 2020 was 12.08 a 2.41% increase of 0.29 from 2019
Other Valuation Metrics:
  • Acadia Pharmaceutica Market Cap for the quarter ending March 03, 2018 was $2,802m a -21.48% decrease of -602m year over year
  • Acadia Pharmaceutica Price / Book for the quarter ending March 03, 2018 was 8.34 a 10.81% increase of 0.90 year over year
  • Acadia Pharmaceutica Enterprise Value for the quarter ending March 03, 2018 was $2,461m a -19.25% decrease of -474m year over year
View Chart On Koyfin

Quarterly ACAD EV / Sales (ntm) Data

10/202013.06
10/202012.60
10/202012.08
10/202011.78
10/202011.42
10/202011.47
10/202011.56
10/202011.90
10/202011.93
10/202012.00

Annual ACAD EV / Sales (ntm) Data

202013.06
202012.60
202012.08
202011.78
202011.42
202011.47
202011.56
202011.90
202011.93
202012.00